Saturday, 23 October 2021

Tag Archives: drug developer

Nestle raises stake in food allergy drug developer Aimmune

LONDON: The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year. The deal raises Nestle’s stake to about ...

Read More »